The GLP-1 Question

It began with the venom of a Gila monster, a biological curiosity that sparked a pharmaceutical revolution. The new class of GLP-1 medications promised a near-magical solution to weight loss, and for millions, the initial results were transformative. But what happens when the magic slows down, the scale hesitates, and the body adapts?One year into treatment, the honeymoon phase ends. This is the reality of the plateau, a biological wall documented in the very clinical trials, like STEP 1, that brought these drugs to market. The body, having lost an average of 15 percent of its mass, begins to fight back, establishing a new, hard-fought equilibrium.Dr. Anna Whitfield's investigation takes you inside the real lives of people one year into the shots. Through the stories of patients like Julian, the physician tracking his own metabolic adaptation, and Elena, who is rebuilding her social life without food as the centerpiece, this book explores the shift from a weight-loss fantasy to the complex reality of chronic disease management. This investigation uncovers the science, the struggles, and the strategies for living a full life on the plateau.